Instruction for use: Depo-Provera

Active substance Medroxyprogesterone

ATX code G03AC06Medroxyprogesterone

Pharmacological groups

Estrogens, gestagens; Their homologues and antagonists

Antineoplastic hormonal agents and hormone antagonists

Composition and form of release

Suspension for injection 1 ml

Medroxyprogesterone acetate 150 mg

Auxiliary substances: polyethylene glycol 3350; Polysorbate 80; sodium chloride; Methylparaben; Propylparaben; water for injections

In a disposable syringe and 1 ml vials or in bottles of 3.3 and 6.7 ml; In a pack of cardboard 1 syringe or 1 bottle.

pharmachologic effect

The pharmacological action is gestagenic, antitumoral.

Dosing and Administration

In / m (intramuscularly). Endometrial cancer and kidney cancer: 400-1000 mg per week for several weeks or months, after achieving stabilization, they switch to maintenance therapy - 400 mg per month.

Breast cancer: 500 mg / day for 28 days, then go on a maintenance dose of 500 mg 2 times a week until signs of disease progression.

Immediately before use, the vial should be shaken well so that the injected preparation becomes a homogeneous suspension.

Storage conditions

At a temperature of 20-25 ° C.

Keep out of the reach of children.

shelf life

5 years.

Do not use after the expiration date stated on the package